← Back to patent-cliff list
CAS 914249-67-5
5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-4-iminothiazolidin-2-one
Codes: PIOG-008
Application context (from source-drug indications)
Type 2 diabetesAlogliptin Benzoate/Pioglitazone HydrochlorideType 2 diabetesPioglitazone HydrochloridePulmonary hypertensionPioglitazone HydrochlorideBreast cancerPioglitazone HydrochlorideNon-alcoholic steatohepatitisPioglitazone HydrochlorideCocaine addictionPioglitazone HydrochlorideAlcohol abusePioglitazone Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alogliptin Benzoate/Pioglitazone Hydrochloride | Tier C — Watch / trade | - |
| Pioglitazone Hydrochloride | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(5-ethylpyridin-2-yl)ethan-1-ol→4-nitrophenol→5-ethyl-2-(2-(4-nitrophenoxy)ethyl)pyridine→4-(2-(5-ethylpyridin-2-yl)ethoxy)aniline→ethyl acrylate→ethyl 2-bromo-3-(4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)propanoate→thiourea→5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-4-iminothiazolidin-2-one
2-(5-ethylpyridin-2-yl)ethan-1-ol→4-nitrophenol→5-ethyl-2-(2-(4-nitrophenoxy)ethyl)pyridine→4-(2-(5-ethylpyridin-2-yl)ethoxy)aniline→ethyl acrylate→ethyl 2-bromo-3-(4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)propanoate→thiourea→5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-4-iminothiazolidin-2-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.